PubMed

Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial.

Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Adamo EB, Wilson S, Squadrito F.

Ann Intern Med. 2007 Jun 19;146(12):839-47.PMID: 17577003 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.

Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.

J Bone Miner Res. 2002 Oct;17(10):1904-12.PMID: 12369794 [PubMed - indexed for MEDLINE]Related articles

Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.

Atteritano M, Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Mazzaferro S, D'Anna R, Cannata ML, Gaudio A, Frisina A, Frisina N, Corrado F, Cancellieri F, Lubrano C, Bonaiuto M, Adamo EB, Squadrito F.

J Clin Endocrinol Metab. 2007 Aug;92(8):3068-75. Epub 2007 May 22.PMID: 17682090 [PubMed - indexed for MEDLINE]Related articlesFree article

Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial.

Zhang G, Qin L, Shi Y.

J Bone Miner Res. 2007 Jul;22(7):1072-9.PMID: 17419678 [PubMed - indexed for MEDLINE]Related articles

Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study.

Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, Minutoli L, Atteritano M, Levy RM, D'Anna R, Frisina N, Mazzaferro S, Cancellieri F, Cannata ML, Corrado F, Frisina A, Adamo V, Lubrano C, Sansotta C, Marini R, Adamo EB, Squadrito F.

J Clin Endocrinol Metab. 2008 Dec;93(12):4787-96. Epub 2008 Sep 16.PMID: 18796517 [PubMed - indexed for MEDLINE]Related articles

Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.

Holloway L, Kohlmeier L, Kent K, Marcus R.

J Clin Endocrinol Metab. 1997 Apr;82(4):1111-7.PMID: 9100582 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.

Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR.

Ann Intern Med. 1996 Sep 1;125(5):360-8.PMID: 8702086 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.

Cheung AM, Tile L, Lee Y, Tomlinson G, Hawker G, Scher J, Hu H, Vieth R, Thompson L, Jamal S, Josse R.

PLoS Med. 2008 Oct 14;5(10):e196. Erratum in: PLoS Med. 2008 Dec;5(12):e247. PMID: 18922041 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.PMID: 18035193 [PubMed - indexed for MEDLINE]Related articles

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.

Osteoporos Int. 2006;17(5):716-23. Epub 2006 Feb 3.PMID: 16463007 [PubMed - indexed for MEDLINE]Related articles

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.

Jolly EE, Bjarnason NH, Neven P, Plouffe L Jr, Johnston CC Jr, Watts SD, Arnaud CD, Mason TM, Crans G, Akers R, Draper MW.

Menopause. 2003 Jul-Aug;10(4):337-44.PMID: 12851517 [PubMed - indexed for MEDLINE]Related articles

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.

Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner JC, Lombardi A, Black DM; Fracture Intervention Trial Long-Term Extension Research Group.

J Bone Miner Res. 2004 Aug;19(8):1259-69. Epub 2004 Mar 29.PMID: 15231012 [PubMed - indexed for MEDLINE]Related articles

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.

Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR; FLEX Research Group.

JAMA. 2006 Dec 27;296(24):2927-38.PMID: 17190893 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Effects of the phytoestrogen genistein on bone health in postmenopausal women.

[No authors listed]

Ann Intern Med. 2007 Jun 19;146(12):I34. No abstract available. PMID: 17577001 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.

Hernández E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR.

Kidney Int. 2003 Jun;63(6):2269-74.PMID: 12753317 [PubMed - indexed for MEDLINE]Related articles

Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.

Välimäki MJ, Laitinen K, Patronen A, Puolijoki H, Seppänen J, Pylkkänen L, Aranko SM, Sairanen S, Blåfield H, Rekiaro M, Väisänen K, Kormano M, Mäkinen L, Salmi J, Ala-Kaila K, Perttilä J, Vesterinen K, Koivunoro K; Probone Study Group.

Osteoporos Int. 2002 Dec;13(12):937-47.PMID: 12459936 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.

Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M.

JAMA. 2003 Aug 27;290(8):1042-8.PMID: 12941676 [PubMed - indexed for MEDLINE]Related articlesFree article

Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia.

Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R.

J Am Soc Nephrol. 2006 Nov;17(11):3213-22. Epub 2006 Oct 11.PMID: 17035614 [PubMed - indexed for MEDLINE]Related articlesFree article

OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration.

Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Cancellieri F, Faraci M, Marini R, Adamo EB, Wilson S, Squadrito F.

J Bone Miner Res. 2008 May;23(5):715-20.PMID: 18433304 [PubMed - indexed for MEDLINE]Related articles